Frontlight ResearchEarly access
Trial site
University of Massachusetts Worcester
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting2 trials
- Terminated2 trials
- Completed1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Gilead Sciences2 trials
- Abbott Medical Devices1 trial
- Abivax S.A.1 trial
- Biogen1 trial
- Craig Anderson1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- Lung cancer1 recruiting
Closed trials
Terminated
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
Recruiting
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026